ArticleFrontiers in public health2026
The compatibility of diagnosis-intervention packet with the individualized treatment paradigm of traditional Chinese medicine: an analytical study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Traditional medicine (TM), including Traditional Chinese Medicine (TCM), serves as a vital component of global healthcare, yet lags behind modern medicine in standardized evaluation and payment model compatibility. In China, TCM's unique paradigm-centered on syndrome differentiation and non-surgical therapies-faces challenges under the Diagnosis-Intervention Packet (DIP) payment reform. However, systematic evidence on how DIP affects medical expenses across different levels of TCM service utilization remains scarce. This study aims to quantify DIP's effects on medical expenses between different groups, and to provide evidence for adjusting DIP policies based on TCM hospital characteristics. Method: We conducted a multiple-group interrupted time series analysis (MGITSA) on outcome variables reflecting hospitalization costs and TCM service structures, using a dataset containing 48,398 inpatient records from a TCM hospital in City C spanning from January 2018 to January 2021. The dataset included 4,343 records for the High-TCM group and 44,055 records for the Low-TCM group. Results: MGITSA indicated that after DIP implementation, the High-TCM group experienced significant increases in both hospitalization costs ( Conclusion: DIP exerts distinct short-term effects: the high-TCM group maintained cost stability, while the low-TCM group exhibited cost inflation. Policy adjustments, such as differential DIP scoring based on TCM treatment rates, are needed to enhance compatibility and support TCM's sustainable development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.